Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events

OBJECTIVE: To assess the potential impact of Pharmacogenomic (PGx) variation in cytochrome P450 2D6 (CYP2D6) enzyme function, using loss in quality-adjusted life years (QALYs) associated with treatment problems, and the willingness to pay to avoid treatment problems from patients’ and payers’ perspe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ye, Lopes, Guilherme S., Bielinski, Suzette J., Borah, Bijan J., Larson, Nicholas B., Moyer, Ann M., Olson, Janet E., Wang, Liewei, Weinshilboum, Richard, St. Sauver, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930862/
https://www.ncbi.nlm.nih.gov/pubmed/33718782
http://dx.doi.org/10.1016/j.mayocpiqo.2020.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930862/
https://www.ncbi.nlm.nih.gov/pubmed/33718782
http://dx.doi.org/10.1016/j.mayocpiqo.2020.08.009

Ejemplares similares